Yahoo Finance

Aytu BioPharma Announces Highest Weekly Adzenys XR-ODT(R) Prescriptions Generated Since Inception of RxConnect

ENGLEWOOD, CO / ACCESSWIRE / November 30, 2022 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused ...
Yahoo Finance

Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major ...

DENVER, CO / ACCESS Newswire / December 15, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central ...
Seeking Alpha

Aytu BioPharma outlines EXXUA launch strategy and expects breakeven at $17.3M quarterly net revenue as ADHD portfolio remains resilient

Selhorn reiterated that the December quarter reflected “just a small initial product load-in, which was in line with expectations.” He said, “With the launch now underway for the March 2026 quarter, ...
inforum

Goodno, Pawlenty tout RxConnect additions

Online buyers of prescription medicine now have another option through the state of Minnesota. MinnesotaRxConnect.com will now offer prescription drugs from two United Kingdom pharmacies as well as ...